MedPath

ZINACEF INJECTION - PWS IM IV 750MG/VIAL

ZINACEF INJECTION - PWS IM IV 750MG/VIAL

Discontinued
DIN Number

02213532

Drug Class

Human

Market Date

Aug 20, 2001

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02213532
AIG Number0113736002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DC02 CEFUROXIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous ,  Intramuscular
AHFS Classification08:12.06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFUROXIME SODIUMActive
Strength: 750 MG / VIAL
Monograph: CEFUROXIME SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.